Published: 29 September 2011
Medical researchers launch campaign to influence MEPs on new clinical trials rules
Nuala Moran, Science|Business
Sixteen of Europe’s top medical research bodies state their case for urgent reform of clinical trials regulations as they begin to prepare the ground for the parliamentary debate on rule changes, expected next year
Liselotte Højgaard, chair of the European Medical Research Councils, thinks regulation for clinical trials is too bureaucratic. Image: Forskning & Medicin
Europe’s leading academic research bodies are today (26 September) appealing to Members of the European Parliament (MEPs) to push for a streamlining of the approval process for clinical trials, saying the current rules are holding back medical progress. Revision needs to focus on getting rid of bureaucracy, they say in a statement.
“It’s vital the recommendations put forward in this statement are taken forward,” says Liselotte Højgaard, chair of the European Medical Research Councils. “The current system...
This page requires a Science|Business Network Membership
This page is available to Science|Business Network Members only. If you are already a member then please log in (above).
Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.
Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.
Be where innovation begins – become a member. Click here to learn more.